About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Analysis of Antihypertensive Treatment Efficacy

NCT00767247·13 sites·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

arterial hypertension
intake of Atacand before study enrollment

You may not be if

hypersensitivity to candesartan or any other ingredient of Atacand
liver function impairment and/or cholestasis
severe renal insufficiency (serum creatinine \> 265 µmol/L)
Pregnant and lactating women

The record

StatusTerminated

PhaseNo phase

Taking part2,000

StartedMay 2008

UpdatedDec 3, 2010

Conditions

Arterial Hypertension

Where13

Research Site
Arhangelsk, Russia
Research Site
Bryansk, Russia
Research Site
Domodedovo, Russia

Clareo Health | Analysis of Antihypertensive Treatment Efficacy